These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 9630674)

  • 1. Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse.
    Braschi S; Couture N; Gambarotta A; Gauthier BR; Coffill CR; Sparks DL; Maeda N; Schultz JR
    Biochim Biophys Acta; 1998 Jun; 1392(2-3):276-90. PubMed ID: 9630674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake.
    Dichek HL; Brecht W; Fan J; Ji ZS; McCormick SP; Akeefe H; Conzo L; Sanan DA; Weisgraber KH; Young SG; Taylor JM; Mahley RW
    J Biol Chem; 1998 Jan; 273(4):1896-903. PubMed ID: 9442022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial lipase promotes the catabolism of ApoB-containing lipoproteins.
    Broedl UC; Maugeais C; Millar JS; Jin W; Moore RE; Fuki IV; Marchadier D; Glick JM; Rader DJ
    Circ Res; 2004 Jun; 94(12):1554-61. PubMed ID: 15117821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen increases hepatic lipase levels in inbred strains of mice: a possible mechanism for estrogen-dependent lowering of high density lipoprotein.
    Srivastava N; Chowdhury PR; Averna M; Srivastava RA
    Mol Cell Biochem; 2001 Apr; 220(1-2):87-93. PubMed ID: 11451387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity.
    Zambon A; Deeb SS; Bensadoun A; Foster KE; Brunzell JD
    J Lipid Res; 2000 Dec; 41(12):2094-9. PubMed ID: 11108744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hypoalphalipoproteinemia in mice expressing human hepatic lipase deficient in binding to heparan sulfate proteoglycan.
    Brown RJ; Gauthier A; Parks RJ; McPherson R; Sparks DL; Schultz JR; Yao Z
    J Biol Chem; 2004 Oct; 279(41):42403-9. PubMed ID: 15292235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic lipase deficiency.
    Connelly PW; Hegele RA
    Crit Rev Clin Lab Sci; 1998 Dec; 35(6):547-72. PubMed ID: 9885775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of human hepatic lipase and ApoE in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions.
    Barbagallo CM; Fan J; Blanche PJ; Rizzo M; Taylor JM; Krauss RM
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):625-32. PubMed ID: 10073966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
    Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
    Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease.
    Jansen H; Hop W; van Tol A; Bruschke AV; Birkenhäger JC
    Atherosclerosis; 1994 May; 107(1):45-54. PubMed ID: 7945558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein metabolism in subjects with hepatic lipase deficiency.
    Tilly-Kiesi M; Schaefer EJ; Knudsen P; Welty FK; Dolnikowski GG; Taskinen MR; Lichtenstein AH
    Metabolism; 2004 Apr; 53(4):520-5. PubMed ID: 15045702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rabbit as an animal model of hepatic lipase deficiency.
    Clay MA; Hopkins GJ; Ehnholm CP; Barter PJ
    Biochim Biophys Acta; 1989 Apr; 1002(2):173-81. PubMed ID: 2930766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
    Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ligand-binding function of hepatic lipase modulates the development of atherosclerosis in transgenic mice.
    González-Navarro H; Nong Z; Amar MJ; Shamburek RD; Najib-Fruchart J; Paigen BJ; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 2004 Oct; 279(44):45312-21. PubMed ID: 15304509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.
    Weidman SW; Ragland JB; Sabesin SM
    J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients.
    Oi K; Hirano T; Sakai S; Kawaguchi Y; Hosoya T
    Kidney Int Suppl; 1999 Jul; 71():S227-8. PubMed ID: 10412783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice.
    Dichek HL; Johnson SM; Akeefe H; Lo GT; Sage E; Yap CE; Mahley RW
    J Lipid Res; 2001 Feb; 42(2):201-10. PubMed ID: 11181749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.